L26/O-157 An emerging hypothesis: the endometrial environment as a key determinant of frozen embryo implantation success
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Habeichi und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does endometrial immune dysregulation reduce live birth rates in IVF, and can immune profiling–guided treatment improve outcomes in fresh and frozen embryo transfer (ET)? Summary answer In frozen ET cycles, endometrial immune dysregulation was associated with lower LBR, while immune profiling–guided treatment improved outcomes in dysregulated patients. What is known already Endometrial immune dysregulation has been implicated in implantation failure and adverse IVF outcomes. The use of frozen ET is increasing worldwide; however, the clinical relevance of the endometrial immune environment and the benefit of immune-targeted interventions in fresh versus frozen ET cycles remain unclear. Study design, size, duration This prospective study included 493 good-prognosis IVF patients who underwent endometrial immune profiling prior to fresh or frozen ET from October 2015 to February 2023. Patients with endometrial immune dysregulation were randomised to treatment groups. The study was conducted after informed consent and was periodically reviewed by a Data and Safety Monitoring Board. Participants/materials, setting, methods Patients underwent endometrial immune profiling before ET. Those with a balanced immune profile received conventional care. Patients with endometrial immune dysregulation were randomised to either conventional care or immune profiling–guided treatment tailored to their local immune status. Live birth rates were compared according to immune profile, type of ET (fresh or frozen), and treatment strategy. Analyses used a modified intention-to-treat approach (excluding patients without ET) and were adjusted for embryo quality and transfer rank. Main results and the role of chance Live birth rate was evaluated according to local immune status and embryo transfer type. In frozen embryo transfer, women with a balanced immune profile achieved higher live birth rate than dysregulated patients receiving standard conventional care (52.4 versus 14.7 percent; adjusted OR 5.32, 95 CI 1.53–20.92). Among dysregulated patients undergoing frozen transfer, endometrial immune profiling–guided treatment was associated with a substantial increase in live birth rate compared to conventional care (48.6 versus 14.7 percent; OR 5.03, 95 CI 1.66–17.63). In fresh embryo transfer, live birth rate was similar between balanced and dysregulated patients receiving standard conventional care (34.5 versus 34.5 percent; OR 1.09, 95 CI 0.55–2.18). Immune profiling–guided treatment did not improve live birth rate in fresh transfers compared with standard conventional management (37.9 versus 34.5 percent; OR 1.19, 95 CI 0.68–2.08).Clinical pregnancy followed the same transfer-specific pattern. No treatment-related serious adverse events were observed. Limitations, reasons for caution Interpretation is limited by the number of frozen embryo transfers and of patients with balanced immune profiles, the multifactorial nature of implantation and open-label IVF design. The single-centre setting limits generalizability, and immune profiling did not assess other key cells including macrophages, dendritic and T regulatory cells. Wider implications of the findings Frozen ET accounts for a substantial proportion of IVF cycles worldwide. Assessment of endometrial immune dysregulation prior to FET may not only identify patients at risk of poor outcomes but also provide a valuable evaluation for all women undergoing FET. Multicenter randomized controlled trials are required to confirm these findings. Trial registration number Yes
Zitieren
APA
Habeichi, N., Lédée, N., Rahmati, M., Dray, G., Kerkhoven, N., Vicaut, E., Diallo, A., Cassuto, N., Ruoso, L., Prat-Ellenberg, L., & Petitbarat, M. (2026). L26/O-157 An emerging hypothesis: the endometrial environment as a key determinant of frozen embryo implantation success. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.155
Vancouver
Habeichi N, Lédée N, Rahmati M, Dray G, Kerkhoven N, Vicaut E, et al. L26/O-157 An emerging hypothesis: the endometrial environment as a key determinant of frozen embryo implantation success. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.155
BibTeX
@article{Habeichi2026,
author = {Habeichi, N. and Lédée, N. and Rahmati, M. and Dray, G. and Kerkhoven, N. and Vicaut, E. and Diallo, A. and Cassuto, N.G. and Ruoso, L. and Prat-Ellenberg, L. and Petitbarat, M.},
title = {L26/O-157 An emerging hypothesis: the endometrial environment as a key determinant of frozen embryo implantation success},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.155}
}
EUVIMED